On average, it helps lose 8% of your weight, which is slightly lower compared to the other two
Mounjaro is approved for managing type 2 diabetes, while Zepbound is suited for chronic weight management in adults with obesity or those who are overweight with related health conditions
Sivandzade F, Bhalerao A, Cucullo L
Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from, and greater than, those in the United States, including additional preclinical studies or clinical trials, as clinical trials conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions
iScience Bazedoxifene rescues hepatocytes from chemically induced oxidative ferroptotic injury in vivo and in vitro by inhibiting protein disulfide isomerase
The majority of pending cases are filed against Novo Nordisk, the makers of Ozempic